Silence Therapeutics advanced its RNAi drug for polycythemia vera, shared new Phase 2 trial updates, and reaffirmed a strong ...

DecisionDx-Melanoma continues to demonstrate strong performance in helping physicians make more informed, risk-aligned ...

PARIS, April 10 (Reuters) - French mining group Eramet (ERMT.PA), opens new tab said on Wednesday it had reached an agreement with the French government to continue its subsidiary SLN's mining ...

French mining company Eramet said on Tuesday that New Caledonia had granted export authorisations for Eramet's SLN arm for up to 2 million tons of nickel ore, bringing its annual export authorisation ...

FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating the ...

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the ...

BMO Capital Markets said it views BioMarin Pharmaceutical (NASDAQ:BMRN), Legend Biotech (NASDAQ:LEGN) and Silence Therapeutics (NASDAQ:SLN) as attractive takeover targets following Eli Lilly’s (LLY) ...